Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC351110756;10757;10758 chr2:178757689;178757688;178757687chr2:179622416;179622415;179622414
N2ABNoneNone chr2:Nonechr2:None
N2ANoneNone chr2:Nonechr2:None
N2BNoneNone chr2:Nonechr2:None
Novex-1346510618;10619;10620 chr2:178757689;178757688;178757687chr2:179622416;179622415;179622414
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTA
  • RefSeq wild type template codon: CAT
  • Domain: Ig-25
  • Domain position: 47
  • Structural Position: 121
  • Q(SASA): 0.6656
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/A None None None None None 0.233 None gnomAD-4.0.0 1.59114E-06 None None None None I None 5.65291E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.2535 likely_benign None None -1.709 Destabilizing None None None None None None None None I
V/C 0.8464 likely_pathogenic None None -1.099 Destabilizing None None None None None None None None I
V/D 0.63 likely_pathogenic None None -2.071 Highly Destabilizing None None None None None None None None I
V/E 0.4709 ambiguous None None -1.939 Destabilizing None None None None None None None None I
V/F 0.2591 likely_benign None None -1.092 Destabilizing None None None None None None None None I
V/G 0.4253 ambiguous None None -2.168 Highly Destabilizing None None None None None None None None I
V/H 0.7315 likely_pathogenic None None -1.995 Destabilizing None None None None None None None None I
V/I 0.0858 likely_benign None None -0.476 Destabilizing None None None None None None None None I
V/K 0.4734 ambiguous None None -1.526 Destabilizing None None None None None None None None I
V/L 0.2371 likely_benign None None -0.476 Destabilizing None None None None None None None None I
V/M 0.1505 likely_benign None None -0.34 Destabilizing None None None None None None None None I
V/N 0.5012 ambiguous None None -1.575 Destabilizing None None None None None None None None I
V/P 0.9293 likely_pathogenic None None -0.856 Destabilizing None None None None None None None None I
V/Q 0.5117 ambiguous None None -1.538 Destabilizing None None None None None None None None I
V/R 0.4169 ambiguous None None -1.238 Destabilizing None None None None None None None None I
V/S 0.3867 ambiguous None None -2.129 Highly Destabilizing None None None None None None None None I
V/T 0.2125 likely_benign None None -1.871 Destabilizing None None None None None None None None I
V/W 0.8828 likely_pathogenic None None -1.583 Destabilizing None None None None None None None None I
V/Y 0.7081 likely_pathogenic None None -1.185 Destabilizing None None None None None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.